The Effect of Intermittent and Continuous Feeding on Growth and Discharge Time in Very Low Birth Weight Preterm

Melek Selalmaz1, Gulzade Uysal2, Umut Zubarioglu1

  • 1Department of Pediatrics, Division of Neonatology, University of Health Sciences Turkey, Sisli Hamidiye Etfal Teaching and Research Hospital, Istanbul, Turkey.

Sisli Etfal Hastanesi Tip Bulteni
|May 3, 2021
PubMed

Insights

Continuous and intermittent bolus feeding show no significant differences in growth or discharge times for very low birth weight infants. However, necrotizing enterocolitis developed earlier with intermittent feeding.

Area of Science:

  • Neonatalogy
  • Pediatric Nutrition
  • Clinical Research

Background:

  • Optimizing feeding strategies for very low birth weight (VLBW) infants is crucial for their development and hospital outcomes.
  • Intermittent bolus feeding and continuous feeding are two common methods, each with potential benefits and drawbacks.

Purpose of the Study:

  • To compare the effects of intermittent bolus feeding versus continuous feeding on early growth and hospital discharge timing in VLBW infants.
  • To assess the incidence and timing of necrotizing enterocolitis (NEC) in VLBW infants under different feeding regimens.

Main Methods:

  • A prospective, randomized, controlled study involving 80 VLBW infants (birth weight <1500 g).
  • Infants were randomized to receive either intermittent bolus feeding or continuous feeding.
  • Key outcomes including growth parameters, time to reach birth weight, feeding tolerance, mechanical ventilation duration, and NEC development were compared.

Main Results:

  • No statistically significant differences were observed in gender, gestational age, birth weight, height, head circumference, time to regain birth weight, maximum weight loss, parenteral feeding duration, or time to full enteral/oral feeding between the groups.
  • Hospitalization time in the intensive care unit and duration of mechanical ventilation were also comparable.
  • While not statistically significant, Necrotizing Enterocolitis (NEC) Stage I and II developed in 34.1% of the continuous feeding group and 28.2% of the intermittent group, with onset occurring earlier in the intermittent group (2.8 days vs. 4.5 days).

Conclusions:

  • Neither continuous nor intermittent bolus feeding significantly impacted growth parameters or discharge times in VLBW infants.
  • Although NEC development rates were similar, the intermittent bolus feeding model was associated with an earlier onset of NEC.
Abstract

Related Concept Videos

Drug Accumulation During Multiple Dosing: Intermittent IV Infusions01:24

Drug Accumulation During Multiple Dosing: Intermittent IV Infusions

Intermittent intravenous (IV) infusion is a method of drug administration where medications are delivered over short infusion periods followed by intervals of no drug delivery. This approach helps to prevent sustained high drug concentrations in the bloodstream, reducing the risk of adverse effects associated with prolonged exposure. Unlike continuous infusion, steady-state concentrations may not be achieved during a single dosing cycle but can be reached through repeated...
66
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
56
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
89
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
64